Regulating man-made derivatives poses several challenges. One issue is the sheer volume and diversity of synthetic chemicals, which makes comprehensive testing and regulation difficult. Additionally, the rapid pace of chemical innovation often outstrips the ability of regulatory bodies to evaluate new substances thoroughly. There is also the challenge of balancing the benefits of these derivatives against their potential risks, especially when they contribute significantly to industry or public health.
